Why Has Oxford Biomedica (LSE:OXB) Become London's Most Debated Cell Therapy Name?

Why Has Oxford Biomedica (LSE:OXB) Become London's Most Debated Cell Therapy Name? →

Highlights An outlook reset at the cell and gene therapy manufacturer triggered a sharp reappraisal by analysts. The group has spent recent years converting itself into a pure contract development and manufacturing operation. Order book con…